Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies

We investigated the effect of the long-acting muscarinic antagonist aclidinium bromide on chronic obstructive pulmonary disease (COPD) exacerbations by pooling data from five randomized, placebo-controlled, parallel-group Phase III studies of 3–6 months’ duration. Data were pooled from the aclidiniu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wedzicha, Jadwiga A., Agusti, Alvar, Donaldson, Gavin, Chuecos, Ferran, Lamarca, Rosa, Garcia Gil, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152596/
https://www.ncbi.nlm.nih.gov/pubmed/27159613
http://dx.doi.org/10.3109/15412555.2016.1170111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152596/
https://www.ncbi.nlm.nih.gov/pubmed/27159613
http://dx.doi.org/10.3109/15412555.2016.1170111

Ejemplares similares